Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.8B | 15.5B | 15.4B | 15.1B |
Cost of revenue | 15.2B | 12.9B | 12.4B | 11.9B |
Gross profit | 2.7B | 2.5B | 3.0B | 3.2B |
Operating expense | ||||
Research & development | 227.5M | 263.3M | 349.8M | 443.8M |
Selling general and admin | 458.2M | -652.3M | 914.7M | -24.3M |
Other operating expenses | 94.7M | 103.5M | 90.3M | 114.3M |
Operating income | 2.0B | 1.6B | 2.2B | 2.2B |
Non operating interest income | ||||
Income | 61.1M | 163.6M | 73.4M | 89.2M |
Expense | 521.7M | 864.3M | 540.0M | 552.8M |
Other income expense | — | — | — | — |
Pretax income | 1.8B | 1.6B | 1.5B | 1.9B |
Tax provision | 105.3M | 254.1M | 54.5M | 82.0M |
Net income | 1.7B | 1.4B | 1.4B | 1.8B |
Basic EPS | 0.7 | — | — | — |
Diluted EPS | 0.7 | — | — | — |
Basic average shares | 1.7B | — | — | — |
Diluted average shares | 1.8B | — | — | — |
EBITDA | 2.2B | 3.1B | 2.0B | 2.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -484.1M | -240.4M | -64.0M | -631.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |